Prescient Therapeutics targets rare T-cell cancer in new clinical trial, doses first patient

By Proactive Investors / May 28, 2025 / www.youtube.com / Article Link

Prescient Therapeutics Ltd CEO James McDonnell talked with Proactive about the initiation of a Phase 2A clinical trial for the ...

Recent News

Big Gold still struggling overall in 2026

September 28, 2026 / www.canadianminingreport.com

Gold stocks down on metal price pullback

September 28, 2026 / www.canadianminingreport.com

Mining sector far outpaces tech over past three years

September 21, 2026 / www.canadianminingreport.com

Gold stocks down with GDXJ outperforming on rebalancing

September 21, 2026 / www.canadianminingreport.com

Copper slides as US apparently wavering on tariff hikes

September 14, 2026 / www.canadianminingreport.com

See all >